The implications of shared symptoms and signs, for forensic clinicians, primary healthcare, and emergency practitioners, as well as other frontline service providers, are discussed.Bugeja, LyndalDepartment of Forensic Medicine, Monash University, Southbank, Melbourne, AustraliaRowse, Janine...
COVID-19 remains a global health concern in 2024, with the XBB.1.5 variant remaining the dominant strain. The symptoms of the XBB.1.5 variant are similar to those of previous strains. High-risk groups for COVID-19 remain the same as last year, and it's essential to continue taking preve...
As described in the introduction, the DASS-21 scale asks respondents to answer 21 questions focused on experiencing symptoms of depression, anxiety, and stress in the past week. Participants were given a choice to choose either the DASS-21 Malaysian version or English version based on their ease...
That same attitude seems to be true of virtually all the modelling, including here in Australia. So many models have implausible assumptions built in, such as that no citizens left to their own devices would change any behaviour without the despotic, mailed fist of government ordering them to d...
COVID-19 The Diagnosis and Treatment Protocol for COVID-19 in China was used to determine COVID-19 severity: 1) for mild cases, the clinical symptoms were minimal, and there was no sign of pneumonia CT image; 2) for moderate cases, the patients only had a fever and respiratory symptoms...
Psychiatric symptoms are seen in some COVID-19 patients, as direct or indirect sequelae, but it is unclear whether SARS-CoV-2 infection interacts with underlying neuronal or psychiatric susceptibilities. Such interactions might arise from COVID-19 immune
Infected children tend to present with mild clinical symptoms without the classic phenotype of lung pneumonia, and COVID-19 symptoms are easily confused with other influenza-like illnesses, which renders infected children difficult to identify.130 Second, previous studies found that children can be a...
Almost a quarter (24%) of those who became ill reported taking medications to combat COVID-19 symptoms. Vaccination remains a cornerstone of the COVID-19 pandemic response, but broad public support remains elusive. These data can be used by health system decisionmakers, practitioners, advocates ...
Risk of poor COVID-19 outcomes in patients with rheumatic disease seems to be mediated by the presence of comorbidities, treatment with glucocorticoids or rituximab, and high disease activity. People with immune or inflammatory rheumatic disease who experience mild COVID-19 symptoms should stop taking...
COVID-19 has emerged as a widely researched topic and the academia has taken interest in the effects of COVID-19 in various sectors of human life and socie